Picking Up Where GWAS Left Off, NHGRI Uses Sequencing to ID Regulatory Elements for Type 2 Diabetes

NHGRI researchers used DNase-seq, a sequencing technique that targets regulatory regions of the genome, and ChIP-seq, which targets transcription sites, to gain insight into noncoding regions of the genome that GWAS had previously identified as being associated with type 2 diabetes.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.